Evidence map›Paper›PMID 41937661›Full record

ArticleJournal of chemical information and modeling2026

Controllable Protein Design by Prefix-Tuning Protein Language Models.

Jiawei Luo, Jiahao Li, Xianliang Liu, Yang Zhang, Qingcai Chen, Junjie Chen

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiawei LuoSchool of Computer Science and Technology, Harbin Institute of Technology, Shenzhen 518055 Guangdong, China.
Jiahao LiSchool of Computer Science and Technology, Harbin Institute of Technology, Shenzhen 518055 Guangdong, China.
Xianliang LiuSchool of Computer Science and Technology, Harbin Institute of Technology, Shenzhen 518055 Guangdong, China.
Yang ZhangSchool of Science, Harbin Institute of Technology, Shenzhen 518055 Guangdong, China.ORCID 0000-0002-3503-5161
Qingcai ChenSchool of Computer Science and Technology, Harbin Institute of Technology, Shenzhen 518055 Guangdong, China.
Junjie ChenSchool of Computer Science and Technology, Harbin Institute of Technology, Shenzhen 518055 Guangdong, China.ORCID 0000-0002-0483-303X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The design of novel proteins with tailored functionalities presents a transformative approach to addressing pressing biomedical challenges. In this study, we propose PrefixProt, a framework for controllable protein design that employs prefix-tuning to learn virtual tokens as control tags. These virtual tokens are adaptively tailored to diverse protein properties through a data-driven manner and can be combinatorially integrated to enable multiobjective control over protein generation. The effectiveness of PrefixProt was validated through extensive experiments encompassing both protein structure design (e.g., α helix or beta-sheet topologies) and protein function design (e.g., antimicrobial or anticancer peptide activities). Benchmark results demonstrate that prefix virtual tokens efficiently guide the pretrained ProtLM by optimizing a smaller number of trainable parameters, outperforming other parameter-efficient fine-tuning methods and text-guided ProtLMs, particularly in scenarios with limited data availability. More importantly, the compositional flexibility of virtual tokens facilitates the generation of proteins with multiple target properties, substantially expanding the scope of the design possibilities. PrefixProt establishes a robust framework for de novo protein design with promising applications in drug discovery and biomedicine.

Indexed as

Models, MolecularProtein EngineeringProteinsDrug DesignProtein ConformationProteins

Identifiers

PMID41937661
PMCPMC13127579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.